Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alberto Papi

Showing results (151-160 of 428) with videos related to

Pageof 43
Sort By:
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 25, 2003
Small airway morphology and lung function in the transition from normality to chronic airway obstructionAngelo Corsico, Manlio Milanese, Simonetta Baraldo, et al.
Frontiers in Immunology|November 4, 2021
Air Pollution Exposure Impairs Airway Epithelium IFN-β Expression in Pre-School ChildrenMatteo Bonato, Elisa Gallo, Martina Turrin, et al.
European Journal of Internal Medicine|May 21, 2021
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseasesAlvar Agusti, Leonardo M Fabbri, Eugenio Baraldi, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2010
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary diseaseJohn A Marwick, Gaetano Caramori, Paolo Casolari, et al.
Lancet (London, England)|September 7, 2016
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trialDave Singh, Alberto Papi, Massimo Corradi, et al.
Expert Review of Clinical Immunology|July 20, 2023
Update on virus-induced asthma exacerbationsFrancesca Urbani, Marianna Cometa, Chiara Martelli, et al.
Respiratory Research|January 22, 2021
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness studyHelgo Magnussen, Sarah Lucas, Therese Lapperre, et al.
The European Respiratory Journal|September 8, 2018
Inhaled corticosteroids in COPD: friend or foe?Alvar Agusti, Leonardo M Fabbri, Dave Singh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 15, 2025
Albuterol-budesonide rescue inhaler for asthma: Patterns of use and safety in the MANDALA trialBradley E Chipps, Reynold A Panettieri, Neil Skolnik, et al.
Respirology (Carlton, Vic.)|July 21, 2022
Treatable traits in the NOVELTY studyAlvar Agustí, Eleni Rapsomaniki, Richard Beasley, et al.
Pageof 43

Showing results (151-160 of 428) with videos related to

Sort By:
Pageof 43
Journal of Applied Physiology (Bethesda, Md. : 1985)|February 25, 2003
Small airway morphology and lung function in the transition from normality to chronic airway obstructionAngelo Corsico, Manlio Milanese, Simonetta Baraldo, et al.
Frontiers in Immunology|November 4, 2021
Air Pollution Exposure Impairs Airway Epithelium IFN-β Expression in Pre-School ChildrenMatteo Bonato, Elisa Gallo, Martina Turrin, et al.
European Journal of Internal Medicine|May 21, 2021
Spirometry: A practical lifespan predictor of global health and chronic respiratory and non-respiratory diseasesAlvar Agusti, Leonardo M Fabbri, Eugenio Baraldi, et al.
The Journal of Allergy and Clinical Immunology|April 13, 2010
A role for phosphoinositol 3-kinase delta in the impairment of glucocorticoid responsiveness in patients with chronic obstructive pulmonary diseaseJohn A Marwick, Gaetano Caramori, Paolo Casolari, et al.
Lancet (London, England)|September 7, 2016
Single inhaler triple therapy versus inhaled corticosteroid plus long-acting β2-agonist therapy for chronic obstructive pulmonary disease (TRILOGY): a double-blind, parallel group, randomised controlled trialDave Singh, Alberto Papi, Massimo Corradi, et al.
Expert Review of Clinical Immunology|July 20, 2023
Update on virus-induced asthma exacerbationsFrancesca Urbani, Marianna Cometa, Chiara Martelli, et al.
Respiratory Research|January 22, 2021
Withdrawal of inhaled corticosteroids versus continuation of triple therapy in patients with COPD in real life: observational comparative effectiveness studyHelgo Magnussen, Sarah Lucas, Therese Lapperre, et al.
The European Respiratory Journal|September 8, 2018
Inhaled corticosteroids in COPD: friend or foe?Alvar Agusti, Leonardo M Fabbri, Dave Singh, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|July 15, 2025
Albuterol-budesonide rescue inhaler for asthma: Patterns of use and safety in the MANDALA trialBradley E Chipps, Reynold A Panettieri, Neil Skolnik, et al.
Respirology (Carlton, Vic.)|July 21, 2022
Treatable traits in the NOVELTY studyAlvar Agustí, Eleni Rapsomaniki, Richard Beasley, et al.
Pageof 43